Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA segregation machinery refers to the collection of protein complexes and genetic elements responsible for the faithful partitioning of DNA during cell division, ensuring that each daughter cell inherits a complete genome. In prokaryotes, this machinery is most commonly represented by systems such as the ParABS complex, which uses centromere-like DNA sites (parS), a motor ATPase (ParA), and a centromere-binding protein (ParB) to mediate segregation of chromosomes or plasmids[1][2][3][4][5]. The process typically involves formation of a partition complex at these specific DNA sequences, assembly of a higher order nucleoprotein structure, and dynamic interactions that drive DNA movement. Eukaryotic DNA segregation relies on more complex assemblies, such as the centromere and its associated kinetochore proteins (e.g., Centromere Protein A/CenpA)[2][6]. The terminology "DNA segregation machinery" generally denotes a system or process, not a single molecular entity or druggable target, and therefore is not considered an individual therapeutic target or receptor[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA segregation machinery.